iBio (IBIO) Current Assets (2011 - 2026)
iBio (IBIO) posted Current Assets of $92.22 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 848.7% from $9.72 million a year earlier and up 19.3% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Current Assets (2011 - 2026) Analysis & Trends
Since fiscal Q4 2011, iBio has reported Current Assets for 61 quarters.
- Annual Current Assets shows a five-year compound annual growth rate of -2.5% (FY2021 to FY2026).
- In prior fiscal years, iBio's Current Assets was $9.72 million in FY2025 (-38.0%), $15.67 million in FY2024 (-40.3%), $26.26 million in FY2023 (-41.7%) and $45.07 million in FY2022 (-56.9%).
- The fiscal Q4 2026 figure stands as the highest quarterly Current Assets since fiscal Q4 2021.
- On a year-over-year basis, Current Assets increased in three of the last seven quarters, with growth averaging 214.0%.
- The strongest year-over-year quarter for Current Assets in the past five years was fiscal Q4 2026, with growth of 848.7%; the weakest was fiscal Q3 2025, with a decline of 83.1%.
- According to Business Quant data, Current Assets for the three prior fiscal quarters was $77.3 million (Q3 2026), $53.4 million (Q2 2026) and $50.8 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 41.36 Bn |
| 10 | iBio | 88.20 Mn | -177.01 Mn | - | 92.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.22 Mn |
| Mar 31, 2026 | 77.30 Mn |
| Dec 31, 2025 | 53.40 Mn |
| Sep 30, 2025 | 50.80 Mn |
| Jun 30, 2025 | 9.72 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 11.71 Mn |
| Jun 30, 2024 | 15.67 Mn |
| Mar 31, 2024 | 36.14 Mn |
| Dec 31, 2023 | 19.70 Mn |
| Sep 30, 2023 | 23.02 Mn |
| Jun 30, 2023 | 26.26 Mn |
| Mar 31, 2023 | 27.09 Mn |
| Dec 31, 2022 | 38.24 Mn |
| Sep 30, 2022 | 63.57 Mn |
| Jun 30, 2022 | 45.07 Mn |
| Mar 31, 2022 | 60.32 Mn |
| Dec 31, 2021 | 67.50 Mn |
| Sep 30, 2021 | 89.82 Mn |
API Access
iBio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();